Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 20, 2026Current Diabetes ReportsOpen Access

Beyond Inflammation - A Multidisciplinary Approach to Managing Obesity and Cardiometabolic Risk in Inflammatory Bowel Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

SPSamantha L. PlushPLPeter LitwinSHSangwoo Han

Discussion

Loading...

Member takes

Overview

Review discusses proactive obesity and cardiometabolic management in adults with inflammatory bowel disease, suggesting improved care models.

Key Points

  • This review aims to assess the prevalence of obesity and cardiometabolic risk in adults with inflammatory bowel disease and evaluate management strategies.
  • Review of screening and management strategies for obesity and cardiometabolic risk in IBD patients.
  • Examine therapeutic interventions from lifestyle changes to pharmacotherapy and surgical options.
  • Evaluate existing care models for integration of multidisciplinary approaches.
  • Obesity prevalence in IBD exceeds 40% and is linked to chronic systemic inflammation.
  • Cardiovascular disease is a major mortality risk in IBD, driven by factors like visceral adiposity and insulin resistance.
  • Current IBD service models often overlook proactive management of cardiometabolic risk, indicating a need for integrated care.

Cite This Study

Plush et al. (2026) studied this question.

synapsesocial.com/papers/6a3630f5db0793dc1a537f50https://doi.org/10.1007/s11892-026-01627-4
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1From Gut to Metabolism2026 · 1 citations
  2. 2Obesity-Mediated Inflammation and Its Influence on Inflammatory Bowel Disease: Pathophysiology, Clinical Impact, and Therapeutic Implications2025 · 14 citations
  3. 3Cardiometabolic diseases in patients with inflammatory bowel disease: An evidence-based review2025 · 5 citations
  4. 4Precision Medicine in Inflammatory Bowel Disease: The Emerging Role of Metabolic Dysfunction2026
  5. 5Metabolic Disorders and Inflammatory Bowel Diseases: Unraveling Shared Pathways and Clinical Interactions2026 · 4 citations